title: Modulation of gastrin processing by vesicular monoamine transporter type 1 (VMAT1) in rat gastrin cells.
abstract: 1. Gastrointestinal endocrine cells produce biogenic amines which are transported into secretory vesicles by one of two proton-amine exchangers, vesicular monoamine transporters type 1 and 2 (VMAT1 and 2). We report here the presence of VMAT1 in rat gastrin (G) cells and the relevance of VMAT1 function for the modulation of progastrin processing by biogenic and dietary amines. 2. In immunocytochemical studies VMAT1, but not VMAT2, was localized to subpopulations of G cells and enterochromaffin (EC) cells; neither was found in antral D cells. The expression of VMAT1 in antral mucosa was confirmed by Northern blot analysis, which revealed an mRNA band of approximately 3.2 kb, and by Western blot analysis, which revealed a major protein of 55 kDa. 3. In pulse-chase labelling experiments, the conversion of the amidated gastrin G34 to G17 was inhibited by biogenic amine precursors (L-DOPA and 5-hydroxytryptophan). This inhibition was stereospecific and sensitive to reserpine (50 nM), which blocks VMAT1 and VMAT2, but resistant to tetrabenazine, which is a selective inhibitor of VMAT2. 4. Dietary amines such as tyramine and tryptamine also inhibited G34 cleavage. This effect was associated with a loss of the electron-dense core of G cell secretory vesicles. It was not stereospecific or reserpine sensitive, but was correlated with hydrophobicity. 5. Thus rat antral G cells can express VMAT1; transport of biogenic amines into secretory vesicles by VMAT1 is associated with inhibition of G34 cleavage, perhaps by raising intravesicular pH. Dietary amines also modulate cleavage of progastrin-derived peptides, but do so by a VMAT1-independent mechanism; they may act as weak bases that passively permeate secretory vesicle membranes and raise intravesicular pH.
authors.affiliation: Physiological Laboratory, University of Liverpool, Liverpool, UK.
authors.forename: I
authors.initials: I
authors.lastname: Hussain
authors.forename: G W
authors.initials: GW
authors.lastname: Bate
authors.forename: J
authors.initials: J
authors.lastname: Henry
authors.forename: P
authors.initials: P
authors.lastname: Djali
authors.forename: R
authors.initials: R
authors.lastname: Dimaline
authors.forename: G J
authors.initials: GJ
authors.lastname: Dockray
authors.forename: A
authors.initials: A
authors.lastname: Varro
mesh_terms: D000596:Amino Acids / Q000008:administration & dosage / Q000502:physiology; D000818:Animals; D002838:Chromaffin System / Q000166:cytology / Q000378:metabolism; D004032:Diet; D004064:Digestive System / Q000166:cytology / Q000378:metabolism*; D004702:Endocrine Glands / Q000166:cytology / Q000378:metabolism*; D005755:Gastrins / Q000378:metabolism*; D007150:Immunohistochemistry; D008297:Male; D008562:Membrane Glycoproteins / Q000096:biosynthesis / Q000378:metabolism*; D026901:Membrane Transport Proteins; D009479:Neuropeptides; D011706:Pyloric Antrum / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D050492:Vesicular Biogenic Amine Transport Proteins; D050493:Vesicular Monoamine Transport Proteins
chemical_list: D000596:Amino Acids; D005755:Gastrins; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009479:Neuropeptides; C493451:Slc18a1 protein, rat; C493454:Slc18a2 protein, rat; D050492:Vesicular Biogenic Amine Transport Proteins; D050493:Vesicular Monoamine Transport Proteins